Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, explains how Drugs for Long-Term is a New Area for Ovarian Cancer Dont give up on path inhibitors too early because of toxicity.
Drugs for Long-Term is a New Area for Ovarian Cancer Dont give up on path inhibitors too early because of toxicity
